Treatment of Gram-negative pneumonia in the critical care setting: is the beta-lactam antibiotic backbone broken beyond repair?

Critical Care : the Official Journal of the Critical Care Forum
Matteo BassettiRichard G Wunderink

Abstract

Beta-lactam antibiotics form the backbone of treatment for Gram-negative pneumonia in mechanically ventilated patients in the intensive care unit. However, this beta-lactam antibiotic backbone is increasingly under pressure from emerging resistance across all geographical regions, and health-care professionals in many countries are rapidly running out of effective treatment options. Even in regions that currently have only low levels of resistance, the effects of globalization are likely to increase local pressures on the beta-lactam antibiotic backbone in the near future. Therefore, clinicians are increasingly faced with a difficult balancing act: the need to prescribe adequate and appropriate antibiotic therapy while reducing the emergence of resistance and the overuse of antibiotics. In this review, we explore the burden of Gram-negative pneumonia in the critical care setting and the pressure that antibiotic resistance places on current empiric therapy regimens (and the beta-lactam antibiotic backbone) in this patient population. New treatment approaches, such as systemic and inhaled antibiotic alternatives, are on the horizon and are likely to help tackle the rising levels of beta-lactam antibiotic resistance. In the meanti...Continue Reading

References

Oct 12, 2000·Pharmacy World & Science : PWS·P P Le BrunH W Frijlink
Apr 6, 2002·American Journal of Respiratory and Critical Care Medicine·Jean Chastre, Jean-Yves Fagon
Apr 20, 2004·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Marc J M BontenJesse B Hall
Feb 9, 2005·American Journal of Respiratory and Critical Care Medicine·UNKNOWN American Thoracic Society, UNKNOWN Infectious Diseases Society of America
Dec 16, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Michael S Niederman
Jan 3, 2006·The European Respiratory Journal·C M LunaUNKNOWN Grupo Argentino de Estudio de la Neumonía Asociada al Respirador group
Dec 5, 2006·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Stephan HarbarthDidier Pittet
Dec 23, 2006·Expert Opinion on Drug Delivery·Rajiv Dhand, Emmanuelle Mercier
Dec 20, 2007·Critical Care Medicine·Daren K HeylandUNKNOWN Canadian Critical Care Trials Group
Jan 4, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Brad SpellbergUNKNOWN Infectious Diseases Society of America
Jul 30, 2008·Drug Development and Industrial Pharmacy·Alan B WattsRobert O Williams
Sep 9, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Marin H Kollef
Nov 28, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Helen W BoucherJohn Bartlett
Jan 16, 2009·The Canadian Journal of Infectious Diseases & Medical Microbiology = Journal Canadien Des Maladies Infectieuses Et De La Microbiologie Médicale·Coleman RotsteinGeorge G Zhanel
Dec 17, 2009·Critical Care : the Official Journal of the Critical Care Forum·Charles-Edouard LuytJean Chastre
Dec 30, 2009·Antimicrobial Agents and Chemotherapy·Jared L CrandonDavid P Nicolau
May 27, 2010·Pharmacotherapy·Jennifer LeUNKNOWN Society of Infectious Diseases Pharmacists Aerosolized Antimicrobials Task Force
Jul 6, 2010·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·John G MuscedereDaren K Heyland
Jul 6, 2010·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Antoni TorresJoan Ramón Badia
Jul 6, 2010·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Ronald N Jones
Aug 6, 2010·International Journal of Antimicrobial Agents·Jason A RobertsJeffrey Lipman
Dec 15, 2010·Critical Care Clinics·Robert G Masterton
Apr 5, 2011·The Journal of Antimicrobial Chemotherapy·Reham KakiNick Daneman
Apr 9, 2011·American Journal of Respiratory and Critical Care Medicine·Qin LuUNKNOWN Nebulized Antibiotics Study Group
Jul 29, 2011·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·A-P MagiorakosD L Monnet
Aug 17, 2011·Current Opinion in Critical Care·Jean-François TimsitSylvie Chevret
Aug 20, 2011·American Journal of Respiratory and Critical Care Medicine·Maarten BekaertUNKNOWN Outcomerea Study Group
Aug 27, 2011·Clinics in Chest Medicine·Lucy B Palmer
Sep 20, 2011·Pharmacotherapy·Kristi A TraugottJames S Lewis
Oct 4, 2011·The European Respiratory Journal·S R OttT T Bauer
Oct 28, 2011·Expert Review of Anti-infective Therapy·G Christopher Wood
Nov 25, 2011·Annals of Intensive Care·Nele BrusselaersStijn Blot
Mar 14, 2012·BMJ Open·Jens-Ulrik Stæhr JensenUNKNOWN Procalcitonin And Survival Study (PASS) Group
May 4, 2012·Chest·Brian S SmithJeffrey Fong
Jul 25, 2012·Annals of Intensive Care·Pedro Póvoa, Jorge I F Salluh
Aug 18, 2012·Annals of Intensive Care·Mohd H Abdul-AzizJason A Roberts

❮ Previous
Next ❯

Citations

May 18, 2016·Expert Review of Respiratory Medicine·David P NicolauCharles-Edouard Luyt
Dec 29, 2016·Current Opinion in Infectious Diseases·Mohd H Abdul-AzizJason A Roberts
Feb 17, 2018·Expert Review of Anti-infective Therapy·Ignacio Martin-LoechesAntoni Torres
Jan 16, 2019·Antimicrobial Agents and Chemotherapy·M J MelchersJ W Mouton
Dec 15, 2019·European Journal of Clinical Pharmacology·Shampa DasJianguo Li
Jan 8, 2020·Antimicrobial Agents and Chemotherapy·Cecilia G CarvalhaesMariana Castanheira
May 2, 2019·Frontiers in Medicine·Matteo BassettiDaniele Roberto Giacobbe
Sep 12, 2017·Expert Review of Respiratory Medicine·Katherine L RobertsMarin H Kollef
Jan 18, 2018·Current Opinion in Infectious Diseases·Matteo BassettiMaddalena Peghin
Nov 4, 2020·Future Microbiology·Matteo BassettiDaniele R Giacobbe
Oct 14, 2019·Anaesthesia Critical Care & Pain Medicine·Marc LeoneBoris Jung

❮ Previous
Next ❯

Clinical Trials Mentioned

NCT01969799
NCT01570192
NCT01799993
NCT00805168

Related Concepts

Related Feeds

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Bacterial Pneumonia (ASM)

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Bacterial Pneumonia

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.